Palmitoylethanolamide: A Natural Compound for Health Management
ReviewHumansOther animals
- Design
- Review
- Subjects
- Not stated in the abstract
- Dose used in the study
- Not stated in the abstract
- Duration
- Not stated in the abstract
- What was measured
- What palmitoylethanolamide's anti-inflammatory, analgesic, antimicrobial, immunomodulatory and neuroprotective actions are, how well tolerated it is, and how delivery systems address its poor oral bioavailability
What the authors reported
PEA is well tolerated and without side effects in animals and humans, say the authors, who list applications in immunity, brain health, allergy, pain, joint health, sleep and recovery. They say PEA's poor oral bioavailability has been overcome by delivery systems now licensed as food supplements. No numbers are given.
Limits of this study
A narrative review written by authors employed by or related to Gencor Pacific, which owns the patented PEA formulations Levagen and Levagen+. The abstract gives no numbers and no study-level detail.
Source
PubMed 34069940 · doi:10.3390/ijms22105305
Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.